<VariationArchive VariationID="12290" VariationName="NM_080911.3(UNG):c.392del (p.Pro131fs)" VariationType="Deletion" Accession="VCV000012290" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2015-02-07" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27329" VariationID="12290">
      <GeneList>
        <Gene Symbol="UNG" FullName="uracil DNA glycosylase" GeneID="7374" HGNC_ID="HGNC:12572" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109097597" stop="109110992" display_start="109097597" display_stop="109110992" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="109535398" stop="109548797" display_start="109535398" display_stop="109548797" Strand="+" />
          </Location>
          <OMIM>191525</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_080911.3(UNG):c.392del (p.Pro131fs)</Name>
      <CanonicalSPDI>NC_000012.12:109099236:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109099237" stop="109099237" display_start="109099237" display_stop="109099237" variantLength="1" positionVCF="109099236" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="109537042" stop="109537042" display_start="109537042" display_stop="109537042" variantLength="1" positionVCF="109537041" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P122fs</ProteinChange>
      <ProteinChange>P131fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.109537046del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.109537046del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.109099241del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.109099241del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007284.1" sequenceAccession="NG_007284" sequenceVersion="1" change="g.6632del">
            <Expression>NG_007284.1:g.6632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003362.4" sequenceAccession="NM_003362" sequenceVersion="4" change="c.365del">
            <Expression>NM_003362.4:c.365del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003353.1" sequenceAccession="NP_003353" sequenceVersion="1" change="p.Pro122fs">
            <Expression>NP_003353.1:p.Pro122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080911.3" sequenceAccession="NM_080911" sequenceVersion="3" change="c.392del" MANESelect="true">
            <Expression>NM_080911.3:c.392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_550433.1" sequenceAccession="NP_550433" sequenceVersion="1" change="p.Pro131fs">
            <Expression>NP_550433.1:p.Pro131fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_124" sequenceAccession="LRG_124">
            <Expression>LRG_124:g.6632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_124t1" sequenceAccession="LRG_124t1">
            <Expression>LRG_124t1:c.392del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="191525.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_080911.3(UNG):c.392del (p.Pro131fs) AND Hyper-IgM syndrome type 5" Accession="RCV000013084" Version="27">
        <ClassifiedConditionList TraitSetID="3330">
          <ClassifiedCondition DB="MedGen" ID="C1720958">Hyper-IgM syndrome type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-27" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-02-07" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12958596</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3330" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2409" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with hyper IgM type 5</ElementValue>
                <XRef ID="Immunodeficiency+with+hyper+IgM+type+5/3780" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyper-IgM Immunodeficiency Syndrome, Type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyper-IgM syndrome type 5</ElementValue>
                <XRef ID="MONDO:0011971" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HIGM5</ElementValue>
                <XRef Type="MIM" ID="608106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10581" />
                <XRef ID="10581" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101092" DB="Orphanet" />
              <XRef ID="C1720958" DB="MedGen" />
              <XRef ID="MONDO:0011971" DB="MONDO" />
              <XRef Type="MIM" ID="608106" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33330" SubmissionDate="2015-02-05" DateLastUpdated="2015-02-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="191525.0001_IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5" title="UNG, 1-BP DEL, 462C _IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5" />
        <ClinVarAccession Accession="SCV000033330" DateUpdated="2015-02-07" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with hyper-IgM syndrome-5 (HIGM5; 608106), Imai et al. (2003) identified compound heterozygosity for a 1-bp deletion (C) at nucleotide 462 in exon 2 and a 2-bp deletion (TA) at nucleotide 639 in exon 4 (191525.0002) of the UNG gene. Both mutations resulted in the generation of premature stop codons (at positions 141 and 224 of nuclear UNG, respectively). The parents of the patient were nonconsanguineous.</Attribute>
              <Citation>
                <ID Source="PubMed">12958596</ID>
              </Citation>
              <XRef DB="OMIM" ID="608106" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UNG" />
          </GeneList>
          <Name>UNG, 1-BP DEL, 462C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 462C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191525.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6202379" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4282442|MedGen:C1720958" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003514080" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12958596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12958596</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro131Hisfs*13) in the UNG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in UNG are known to be pathogenic (PMID: 12958596). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 12290). This variant is also known as 462C del. This premature translational stop signal has been observed in individual(s) with hyper IgM syndrome. (PMID: 12958596). This variant is present in population databases (rs778896112, gnomAD 0.005%).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UNG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.109537042del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720958" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33330" TraitType="Disease" MappingType="Name" MappingValue="IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5" MappingRef="Preferred">
        <MedGen CUI="C1720958" Name="Hyper-IgM syndrome type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6202379" TraitType="Disease" MappingType="XRef" MappingValue="C1720958" MappingRef="MedGen">
        <MedGen CUI="C1720958" Name="Hyper-IgM syndrome type 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

